Members of the European Cancer Organisation's Quality Cancer Care Network collectively provide an extensive range of educational and developmental resources to assist healthcare professionals and all involved in cancer care and treatment to develop their knowledge, skills and competences.
We encourage you to familiarise and explore the following resources developed to help individuals in all countries in Europe learn and grow.
The European School of Oncology was founded by Umberto Veronesi and Laudomia Del Drago in 1982, with the aim of contributing to the reduction of deaths from cancer due to late diagnosis and/or inadequate treatment. By improving the skills of all health professionals dealing with cancer patients, ESO helps shorten the time needed to transfer knowledge from research centres to daily practice, combining advanced technology with humanism in care.
Available via its website www.eso.net/ are:
More information is available here.
ESCO is the College of the European School of Oncology. It offers aspiring medical, radiation and surgical oncologists a structured educational pathway that spans their career from medical student through to taking on leadership responsibilities.
In a series of the European Society for Hybrid, Molecular and Translational Imaging (ESHI-MT) online lectures, distinguished experts in the field of hybrid imaging will share their knowledge about various modalities and subspecialties related to the fusion of nuclear medicine and radiology as well as molecular and translational imaging.
The aim of the European Society of Oncology Pharmacy (ESOP) is to support optimal treatment for cancer patients. In order to achieve this aim, ESOP offers high-quality further education opportunities including:
Provided by the Academy of the European Society of Oncology Pharmacy, this 100 hour educational program consists of e-learnings, an international workshop (Excellence Course for Oncology Pharmacy – ExCOP) and national trainings. After passing the whole EUSOP program, the title “European Pharmacist in Oncology Pharmacy” can be achieved.
The programme of the European Conference of Oncology Pharmacy Aims to equip oncology pharmacy practitioners with knowledge about recent developments, advance the effectiveness of healthcare delivery and increase the quality of patient care. State-of-the-art advances in research, patient management and practice are showcased in keynote lectures, scientific symposia and poster sessions in two well-defined tracks: clinical and practical.
The Multinational Association of Supportive Care in Cancer (MASCC) Textbook is intended for medical students, residents, and fellows, as well as oncologists, general practitioners, nurses, and allied health professionals. It is designed to improve management of the symptoms and side effects of cancer and its treatments, with the aim of enhancing quality of life for cancer patients and survivors.
Visit the European Society of Surgical Oncology (ESSO) website to access a great range of accessible educational tools for oncology surgeons, including:
More information is available here.
The European School of Multimodality Imaging & Therapy initiative represents EANM’s response to huge changes in the educational needs of the nuclear medicine community and the rising demand for greater multimodality content.
The offered eLearning content can be accessed on demand and covers various topics which can be viewed for free after logging in with a personal username and password. New users can easily create a confidential account. Find more information on the eLearning platform where the content can be filtered by topic.
In the free live webinars, experts in the field of nuclear medicine share their knowledge about various topics in an interactive online setting accessible from all over the world.
Schools / Advanced Courses
ESMIT widens its wings by offering multiple learning events in Vienna and other European cities each year to provide knowledge and training on multimodality procedures daily applicable in the management of patients with cardiovascular, endocrine, musculoskeletal, neurological and oncological disease.